|
⚲
|
| Keyboard |
| Hummel Albert F
✚
|
|
|---|---|
| CIK # | 0001236489 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001236489] | |
| 4 | [0001236489] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Biotech Acquisition Co | |
| Hummel Albert F | |
| Watson Pharmaceuticals Inc | |
| Obagi Medical Products Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Watson Pharmaceuticals Inc ACT
Common Stock, par value $0.0033
|
2017-09-16 | Gift | 3,800 | $0.00 | |
|
Watson Pharmaceuticals Inc ACT
Common Stock, par value $0.0033
|
2013-10-01 | Disposed to issuer | 82,776 | ||
|
Watson Pharmaceuticals Inc ACT
Common Stock, par value $0.0033
|
2013-09-16 | Sell | 6,200 | $137.81 | 854,422 |
|
Watson Pharmaceuticals Inc ACT
Common Stock, par value $0.0033
|
2013-08-26 | Sell | 15,956 | $134.44 | 2,145,125 |
|
Watson Pharmaceuticals Inc ACT
Common Stock, par value $0.0033
|
2013-08-23 | Sell | 4,044 | $134.16 | 542,543 |
|
Watson Pharmaceuticals Inc ACT
Common Stock, par value $0.0033
|
2013-08-22 | Sell | 20,000 | $134.50 | 2,690,000 |
|
Watson Pharmaceuticals Inc ACT
Common Stock, par value $0.0033
|
2013-08-13 | Option exercise | 5,000 | $30.12 | 150,600 |
|
Watson Pharmaceuticals Inc ACT
Common Stock, par value $0.0033
|
2013-08-13 | Option exercise | 5,000 | $29.03 | 145,150 |
|
Watson Pharmaceuticals Inc ACT
Common Stock, par value $0.0033
|
2013-08-13 | Sell | 10,000 | $133.85 | 1,338,500 |
|
Watson Pharmaceuticals Inc ACT
Non-Qualified Options to Purchase Common Stock · derivative
|
2013-08-13 | Option exercise | 5,000 | $0.00 | |
|
Watson Pharmaceuticals Inc ACT
Non-Qualified Options to Purchase Common Stock · derivative
|
2013-08-13 | Option exercise | 5,000 | $0.00 | |
|
Watson Pharmaceuticals Inc ACT
Common Stock, par value $0.0033
|
2013-05-10 | Grant | 1,877 | $0.00 | |
|
Obagi Medical Products Inc OMPI
Common Stock
|
2013-04-25 | Disposed to issuer | 65,787 | $24.00 | 1,578,888 |
|
Obagi Medical Products Inc OMPI
Stock option (right to buy) · derivative
|
2013-04-25 | Disposed to issuer | 165,000 | $11.30 | 1,864,500 |
|
Obagi Medical Products Inc OMPI
Stock option (right to buy) · derivative
|
2013-04-25 | Disposed to issuer | 100,000 | $11.45 | 1,145,000 |
|
Watson Pharmaceuticals Inc WPI
Common Stock, par value $0.0033
|
2012-05-29 | Sell | 19,000 | $73.74 | 1,401,060 |
|
Watson Pharmaceuticals Inc WPI
Common Stock, par value $0.0033
|
2012-05-11 | Grant | 2,887 | $0.00 | |
|
Watson Pharmaceuticals Inc WPI
Common Stock, par value $0.0033
|
2012-05-02 | Option exercise | 30,000 | $26.60 | 798,000 |
|
Watson Pharmaceuticals Inc WPI
Non-Qualified Options to Purchase Common Stock · derivative
|
2012-05-02 | Option exercise | 30,000 | $0.00 | |
|
Watson Pharmaceuticals Inc WPI
Common Stock, par value $0.0033
|
2012-05-02 | Sell | 10,679 | $74.73 | 798,042 |
| showing 20 of 21 most recent transactions | |||||